Results from the ACTT-2 trial reveal that baricitinib combined with remdesivir reduced the recovery time of hospitalized COVID-19 patients from 8 to 7 days. The reduced recovery time was even more significant in patients requiring…
Gut bacteria can help rebuild the immune system
For the first time, researchers have demonstrated how the gut microbiome — the community of microorganisms living in the gut — can influence the immune system in humans. Their work could lead to new treatments…
